Condition
Acute Ischemic Stroke AIS clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Acute Ischemic Stroke AIS clinical trials that are recruiting, at sites in 10 countries (most in Australia (3), Canada (3), China (3)). By phase: Phase 3 (2), Phase 2 (1), Phase 2/3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 10Countries
Newest Acute Ischemic Stroke AIS clinical trials
All recruiting trials (11)
-
Mobilisation After Endovascular Stroke Treatment
This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.
-
Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS
This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.
-
Real-world performance and safety of the Penumbra System in acute ischemic stroke
This project will test how the Penumbra mechanical thrombectomy system performs and how safe it is in adults aged 18–75 who have acute ischemic stroke and are eligible for clot removal.
-
Balloon guide catheter versus conventional guide catheter for clot removal in ischemic stroke
This study will test whether a balloon guide catheter or a conventional guide catheter works better for adults having a thrombectomy to treat an acute ischemic stroke.
-
IV infusions of human umbilical cord mesenchymal stem cells for acute ischemic stroke (Phase IIa)
This Phase IIa test will see if one or multiple IV infusions of human umbilical cord mesenchymal stem cells help adults with recent acute ischemic stroke recover better and are safe.
-
One-stop approach for rapid start of endovascular clot removal
This trial will test whether taking eligible adults with suspected large- or medium-vessel ischemic stroke straight to the angiography suite for imaging and treatment gets clot-removal therapy started faster and improves outcomes.
-
Galantamine for improving recovery after acute ischemic stroke
This trial will test whether adding galantamine to standard care helps adults with acute ischemic stroke who are treated within 72 hours recover better.
-
Stem cell–derived extracellular vesicle therapy for acute ischemic stroke
This study tests SNE-101, stem cell–derived extracellular vesicles from Wharton's jelly, to see if it is safe and tolerable in adults with acute ischemic stroke.
-
Comparing different doses of tenecteplase for treating acute ischemic stroke
This study is testing whether a standard dose or a lower dose of a medication called tenecteplase can help people who have had an acute ischemic stroke recover better and stay safe.
-
Registry for Endovascular Thrombectomy in Extra-Large Stroke Patients
This study is trying to see how well a procedure called endovascular thrombectomy works for people with very large strokes to help improve their outcomes.
-
Pulse treatment for acute ischemic stroke
This study is testing a new treatment called the Pulse NanoMED System for people who have had an acute ischemic stroke to see if it can help improve blood flow to the brain after they receive standard care.
Related topics
Quick answers
How many Acute Ischemic Stroke AIS clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in Australia (3 trials), Canada (3 trials), China (3 trials), Germany (2 trials), Switzerland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2: 1, Phase 2/3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.